Silence Therapeutics (SLN) Amortizatization of Intangibles (2024 - 2026)
Silence Therapeutics' Amortizatization of Intangibles was $35,000 in the quarter ended Jun 30, 2026, down 47.8% from $67,000 a year earlier but up 2.9% from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Silence Therapeutics' Amortizatization of Intangibles was $180,000 through Jun 30, 2026, down 31.0% year-over-year; for the year ended Dec 31, 2025, it came in at $243,000, down 5.4% from the prior year.
- Amortizatization of Intangibles shows a three-year compound annual growth rate of 3.8% (years ended Dec 2022 to Dec 2025).
- In earlier years, Amortizatization of Intangibles was $257,000 in the year ended Dec 31, 2024 (+2.0%), $252,000 in the year ended Dec 31, 2023 (+16.1%) and $217,000 in the year ended Dec 31, 2022.
- Quarterly Amortizatization of Intangibles has moved between $34,000 (the quarter ended Mar 31, 2026) and $75,000 (the quarter ended Sep 30, 2025) over five years.
- Compared with a year earlier, Amortizatization of Intangibles has declined for three straight quarters, with an average decline of 19.6% over the last six quarters.
- Per Business Quant data, SLN's Amortizatization of Intangibles in the three quarters before the quarter ended Jun 30, 2026 was $34,000 (quarter ended Mar 31, 2026), $36,000 (quarter ended Dec 31, 2025) and $75,000 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 984.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 600.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Silence Therapeutics | 502.70 Mn | 430.60 Mn | - | 35,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 67,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 64,000.00 |
API Access
Silence Therapeutics Amortizatization of Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortizatization-of-intangibles", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();